通过创新的VLP设计来增强NA免疫性
Leticia Guzman Ruiz1, Alexander M Zollner2, Irene Hoxie3
1University of Natural Resources and Life Sciences Vienna (BOKU), Department of Biotechnology, Institute of Molecular Biotechnology (IMBT), Muthgasse 18, 1190 Vienna, Austria; University of Natural Resources and Life Sciences Vienna (BOKU), Department of Biotechnology, Institute of Bioprocess Science and Engineering (IBSE), Muthgasse 18, 1190 Vienna, Austria.
Vaccine
|August 28, 2024
概括
下一代流感疫苗可以通过增强神经氨基酶 (NA) 免疫性来改进. 修改血凝素 (HA):NA比率并将NA茎扩展到类似病毒的粒子 (VLPs) 上,成功地引起了NA-反应性抗体.
科学领域:
- 病毒学 病毒学
- 免疫学 免疫学 免疫学
- 疫苗开发 疫苗开发
背景情况:
- 目前的流感疫苗主要诱导血凝素 (HA) 反应性抗体,对神经氨基酶 (NA) 表观素的疗效有限.
- 下一代疫苗需要优化,以激活NA-反应性B细胞以获得更广泛的保护.
研究的目的:
- 为了增强流感疫苗中NA成分的免疫性.
- 研究改善NA-反应性抗体诱导的策略,同时保持HA免疫性.
主要方法:
- 类似H1N1病毒的粒子 (VLPs) 是使用baculovirus表达系统进行的.
- 策略包括改变HA:NA比率,并通过加入特定的氨基酸来扩展NA茎 (NA-LS).
- 在小鼠模型中净化并测试VLP的免疫性.
主要成果:
- 修改后的VLP实现了1:1到2:1的HA:NA比率,与野生型流感病毒相比增加了NA含量.
- 用H1N1VLP接种疫苗引起了强大的NA抑制抗体标位,即使在低剂量.
- 抗HA反应没有受到修改的影响.
结论:
- 开发的策略是可行的增强在候选流感疫苗的NA免疫性.
- 这些修改显示了创造下一代流感疫苗的潜力,这些疫苗具有更好的和更广泛的保护能力.
相关概念视频
Viral Structure
61.9K
Viruses are extraordinarily diverse in shape and size, but they all have several structural features in common. All viruses have a core that contains a DNA- or RNA-based genome. The core is surrounded by a protective coat of proteins called the capsid. The capsid is composed of subunits called capsomeres. The capsid and genome-containing core are together known as the nucleocapsid.
61.9K
Immune Response Against Viral Pathogens
765
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
765


